From the Human Fertilisation and Embryology Authority in the UK comes this intriguing question about Primary Prevention.
"Should we be allowed to test at conception for conditions such as Alzheimer's?"
A public debate on how far doctors and scientists should be allowed to go with embryo-testing techniques is being launched today by the UK fertility regulator, the Human Fertilisation and Embryology Authority (HFEA). The debate will both focus on current technologies – such as the ability to screen for breast cancer genes – and possible future developments, such as the potential to screen for inherited forms of Alzheimer’s disease.
The HFEA is launching the debate with a discussion paper Choices & boundaries - which looks at key questions raised by the embryo testing technique known as preimplantation genetic diagnosis (PGD). People are being asked give their views on where they feel the boundaries should lie on which conditions PGD can be used to test for.
Leave a comment